Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BMO Capital Initiates Coverage On Teladoc Health with Market Perform Rating, Announces Price Target of $8

Author: Benzinga Newsdesk | November 13, 2025 06:10am
BMO Capital analyst Sean Dodge initiates coverage on Teladoc Health (NYSE:TDOC) with a Market Perform rating and announces Price Target of $8.

Posted In: TDOC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist